We serve Chemical Name:ethyl (2S)-2-[[(3S)-2-oxo-1,3,4,5-tetrahydro-1-benzazepin-3-yl]amino]-4-phenylbutanoate CAS:367909-45-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:ethyl (2S)-2-[[(3S)-2-oxo-1,3,4,5-tetrahydro-1-benzazepin-3-yl]amino]-4-phenylbutanoate
CAS.NO:367909-45-3
Synonyms:(S)-Ethyl 2-(((S)-2-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepin-3-yl)amino)-4-phenylbutanoate;(2S,3’S)-2-(2-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepin-3-ylamino)-4-phenyl-butyric acid ethyl ester;(1’S,3S)-3-[(1′-(ethoxycarbonyl)-3′-phenylpropyl)amino]-2,3,4,5-tetrahydro-2-oxo-1H-benzazepine
Molecular Formula:C22H26N2O3
Molecular Weight:366.45300
HS Code:2933990090
Physical and Chemical Properties:
Melting point:110-111ºC
Boiling point:573.635ºC at 760 mmHg
Density:1.18 g/cm3
Index of Refraction:
PSA:67.43000
Exact Mass:366.19400
LogP:3.62290
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like (S)-Ethyl 2-(((S)-2-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepin-3-yl)amino)-4-phenylbutanoate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(1’S,3S)-3-[(1′-(ethoxycarbonyl)-3′-phenylpropyl)amino]-2,3,4,5-tetrahydro-2-oxo-1H-benzazepine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(S)-Ethyl 2-(((S)-2-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepin-3-yl)amino)-4-phenylbutanoate Use and application,(S)-Ethyl 2-(((S)-2-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepin-3-yl)amino)-4-phenylbutanoate technical grade,usp/ep/jp grade.
Related News: Zynteglo was granted conditional marketing authorisation in May 2019. The conditional authorisation means that there is more evidence to come about the medicine, which the company will provide. EMA regularly reviews new information that becomes available. (E)-3-(2,4-dichlorophenyl)prop-2-enoyl chloride manufacturers Last week, the health ministry estimated the vaccine was only 41% effective at halting symptomatic infections over the past month. Protection against severe disease remained strong at 91%. Ditridecyl adipate suppliers RELATED: With Takhzyro durability data, Takeda tries to fend off BioCryst’s hereditary angioedema challenger Orladeyo Artemotil vendor & factory.